Although PTX3 represents a novel acute‐phase reactant produced at sites of active vasculitis and correlates with disease activity (Ramirez et al., 2019), the vasopathology of SAO is completely different from that of vasculitis. Here, PTX3 is linked to southeast Asian ovalocytosis.